Đảng Bảo thủ của Thủ tướng Boris Johnson duy trì ưu thế trước bầu cử

Theo một cuộc thăm dò dư luận công bố ngày 18/11 trên Good Morning Britain, đảng Bảo thủ của Thủ tướng Anh Boris Johnson tiếp tục dẫn trước Công đảng đối lập về tỷ lệ ủng hộ trước cuộc bầu cử quốc hội ngày 12/12 tới.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh